BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a gastric protein sequence and is commonly discussed in peptide research for its potential relevance to tissue recovery, angiogenesis, anti-inflammatory pathways, gut support, and musculoskeletal healing models
GlyNAC Supplementation in Older Adults Improves Glutathione, Mitochondria, Aging Hallmarks, and Function
5-Amino-1MQ is an investigational compound with no approved human indication
The webpage on Breckas protocols also highlights photobiomodulation ;(an overhyped use of red light, the studies of which are often disappointing), peptides like BPC-157 and TB-500 (trendy, injectable black-market experimental drugs, often abandoned by pharma for lacking benefits or being unsafe), and grounding (the pseudoscientific notion that touching the ground with your bare feet will fill you up with electrons that will reduce oxidative stress)
Neither cagrilintide nor retatrutide is currently approved for clinical use in the United Kingdom
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme